ArticleEuropean heart journal. Digital health2025
Artificial intelligence-based accurate myocardial infarction mapping using 12-lead electrocardiography.
Article in European heart journal. Digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Assessing myocardial fibrosis (MF) in patients with prior myocardial infarction (MI) is crucial for prognosis. Artificial intelligence-assisted electrocardiography (AI-ECG) has a great potential to detect MF. However, training a precise AI-ECG model requires voluminous ECGs. A biosimulation model may be an efficient substitution. This study aimed to develop and validate a novel artificial intelligence-assisted method using 12-lead electrocardiography (AI-MI-12ECG). Methods and results: The AI-MI-12ECG was trained by a biosimulation model to visualize the presence, location, and size of MF in post-MI patients. A total of 182 post-MI patients were included in this prospective study. The MF detected by AI-MI-12ECG and the cardiologist were compared with the late gadolinium-enhanced (LGE) area of cardiac magnetic resonance (CMR). The results show that AI-MI-12ECG exhibited strong correlation with LGE in identifying the MI location ( Conclusion: The AI-MI-12ECG trained using the biosimulation model in post-MI patients was adequately aligned with CMR-LGE. This highlights its potential for accurate detection of fibrosis and identification of individuals with significant infarct burdens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.